Enveric Biosciences, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Enveric Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2023.
  • Enveric Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $369K, a 55.3% decline year-over-year.
  • Enveric Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $1.41M, a 40.8% decline year-over-year.
  • Enveric Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.99M, a 17.5% decline from 2022.
  • Enveric Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.42M, a 80.4% decline from 2021.
  • Enveric Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.3M.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.99M -$422K -17.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $2.42M -$9.89M -80.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $12.3M Jan 1, 2021 Dec 31, 2021 10-K/A 2023-06-09
2019 $1.2M +$600K +100% Jan 1, 2019 Dec 31, 2019 10-K/A 2020-08-12
2018 $600K -$6.5M -91.5% Jan 1, 2018 Dec 31, 2018 10-K/A 2020-08-12
2017 $7.1M +$5.6M +373% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-26
2016 $1.5M Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.